HLA-B*5701 and abacavir hypersensitivity

被引：7
|
作者：
Watson, ME [1 ]
Pimenta, JM
Spreen, WR
Hernandez, JE
机构：
[1] GlaxoSmithKline, Res & Dev, Dept Global Hlth Outcomes, Infect Dis Med Dev Ctr HIV, Res Triangle Pk, NC USA
[2] GlaxoSmithKline, Res & Dev, Dept Epidemiol, Infect Dis Med Dev Ctr HIV, Res Triangle Pk, NC USA
[3] GlaxoSmithKline, Res & Dev, Dept Clin Dev, Infect Dis Med Dev Ctr HIV, Res Triangle Pk, NC USA
来源：
PHARMACOGENETICS | 2004年 / 14卷 / 11期
关键词：
D O I：
10.1097/00008571-200411000-00011
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：783 / 784
页数：2
相关论文
共 50 条
  • [41] Hla-b☆5701 allele is the leading marker of hypersensitivity reactions for abacavir-including therapy in hiv-infected patients
    Begaidarova, R. H.
    Sagimbaev, B. Zh
    Devdariani, Ch. G.
    Alshynbekova, G. K.
    Yukhnevich-Nassonova, Y. A.
    ALLERGY, ASTHMA & IMMUNOPHYSIOLOGY: RECENT ADVANCES IN UNDERSTANDING AND MANAGEMENT, 2015, : 91 - 92
  • [42] Reducing hypersensitivity reactions with HLA-B*5701 genotyping before abacavir prescription: clinically useful but is it cost-effective in Singapore?
    Kapoor, Ritika
    Martinez-Vega, Rosario
    Dong, Di
    Tan, Sharlene Yanying
    Leo, Yee-Sin
    Lee, Cheng-Chuan
    Sung, Cynthia
    Oon-Tek Ng
    Archuleta, Sophia
    Teo, Yik-Ying
    PHARMACOGENETICS AND GENOMICS, 2015, 25 (02): : 60 - 72
  • [43] Severe abacavir hypersensitivity in a patient previously treated without significant adverse reactions by a treatment including abacavir. Usefulness of HLA-B*5701 screening in such a case?
    Andrejak, M.
    Borel, A.
    Airapatian, N.
    Gosset, M.
    Andrejak, C.
    Douadi, Y.
    Gras, V.
    Schmit, J. L.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2009, 23 : 103 - 104
  • [44] Genetic testing for HLA-B*5701 in HIV-infected patients: candidates for abacavir therapy
    Nardi, Gilda
    Massi, Luciano
    Paci, Ornella Onorina
    Grazioli, Marzia
    Gaspari, Paola
    TISSUE ANTIGENS, 2010, 75 (05): : 610 - 610
  • [45] HLA-B*5701 TaqMan assay for abacavir sensitivity: application to PREDICT-1 trial
    Bugawan, T.
    TISSUE ANTIGENS, 2008, 72 (03): : 237 - 237
  • [46] Should HLA-B*5701 Screening Be Performed in Every Ethnic Group before Starting Abacavir?
    Park, Wan Beom
    Choe, Pyoeng Gyun
    Song, Kyoung-Ho
    Lee, Shinwon
    Jang, Hee-Chang
    Jeon, Jae Hyun
    Park, Sang-Won
    Park, Myoung Hee
    Oh, Myoung-don
    Choe, Kang Won
    CLINICAL INFECTIOUS DISEASES, 2009, 48 (03) : 365 - 367
  • [47] HLA-B*5701 TAQMAN ASSAY FOR ABACAVIR SENSITIVITY; APPLICATION TO PREDICT-1 TRIALS
    Bugawan, T.
    Isoda, W.
    Mano, C.
    Blair, A.
    Mallal, S.
    Thorborn, D.
    Erlich, H.
    HUMAN IMMUNOLOGY, 2008, 69 : S89 - S89
  • [48] Validation of a sensitive, specific and rapid pharmacogenomic test for the prediction of abacavir hypersensitivity reaction: detection of HLA-B*5701 by Real-Time PCR
    Dello Russo, C.
    Lisi, L.
    Lofaro, A.
    Di Giambenedetto, S.
    Federico, B.
    Madeddu, G.
    Salerno, M.
    Mura, M. S.
    Pirazzoli, A.
    De Luca, A.
    Cauda, R.
    Navarra, P.
    INFECTION, 2010, 38 : 61 - 61
  • [49] STRONG ASSOCIATION OF HLA-B*5701 WITH ABACAVIR HYPERSENSITIVITY AMONG HIV-1 POSITIVE PATIENTS: A POTENTIAL PHARMACOGENETIC PREDICTIVE TEST.
    Khan, Faisal
    Gill, John
    Berka, Noureddine
    HUMAN IMMUNOLOGY, 2008, 69 : S43 - S43
  • [50] RELEVANCE OF HLA-B*57:01 SCREENING FOR ABACAVIR HYPERSENSITIVITY IN NORTH INDIANS
    Kanga, Uma
    Sharma, Gaurav
    Sharma, Akanksha
    Alwadhi, Ajeet
    Abid, Mohd
    Gautam, Sashi K.
    HUMAN IMMUNOLOGY, 2019, 80 : 106 - 106
12345